Flossbach Von Storch SE Has $648.98 Million Stock Holdings in AMETEK, Inc. (NYSE:AME)

Flossbach Von Storch SE raised its stake in AMETEK, Inc. (NYSE:AME - Free Report) by 1.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,770,066 shares of the technology company's stock after acquiring an additional 45,714 shares during the quarter. AMETEK comprises approximately 2.8% of Flossbach Von Storch SE's investment portfolio, making the stock its 18th biggest holding. Flossbach Von Storch SE owned approximately 1.63% of AMETEK worth $648,979,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in AME. Norges Bank bought a new stake in shares of AMETEK during the fourth quarter worth approximately $697,080,000. Capital World Investors boosted its stake in AMETEK by 70.0% in the fourth quarter. Capital World Investors now owns 5,760,017 shares of the technology company's stock valued at $1,038,301,000 after acquiring an additional 2,371,062 shares during the last quarter. Lazard Asset Management LLC boosted its stake in AMETEK by 393.1% in the fourth quarter. Lazard Asset Management LLC now owns 1,215,087 shares of the technology company's stock valued at $219,030,000 after acquiring an additional 968,661 shares during the last quarter. GAMMA Investing LLC boosted its stake in AMETEK by 18,368.3% in the first quarter. GAMMA Investing LLC now owns 973,280 shares of the technology company's stock valued at $167,540,000 after acquiring an additional 968,010 shares during the last quarter. Finally, American Century Companies Inc. boosted its stake in AMETEK by 240.3% in the fourth quarter. American Century Companies Inc. now owns 1,125,068 shares of the technology company's stock valued at $202,805,000 after acquiring an additional 794,473 shares during the last quarter. Institutional investors and hedge funds own 87.43% of the company's stock.

AMETEK Stock Performance

NYSE AME traded down $0.45 during trading on Friday, reaching $180.99. The company's stock had a trading volume of 839,398 shares, compared to its average volume of 1,303,439. The company has a current ratio of 1.41, a quick ratio of 0.86 and a debt-to-equity ratio of 0.15. The firm has a market capitalization of $41.79 billion, a price-to-earnings ratio of 29.62, a price-to-earnings-growth ratio of 2.72 and a beta of 1.09. AMETEK, Inc. has a 12 month low of $145.02 and a 12 month high of $198.33. The firm has a 50 day moving average price of $178.66 and a 200 day moving average price of $177.05.

AMETEK (NYSE:AME - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The technology company reported $1.75 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.69 by $0.06. The firm had revenue of $1.73 billion during the quarter, compared to the consensus estimate of $1.74 billion. AMETEK had a net margin of 20.43% and a return on equity of 16.75%. The business's revenue for the quarter was down .2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.64 EPS. As a group, equities analysts anticipate that AMETEK, Inc. will post 7.15 EPS for the current fiscal year.

AMETEK Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Friday, June 13th were issued a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a yield of 0.69%. The ex-dividend date of this dividend was Friday, June 13th. AMETEK's dividend payout ratio is currently 20.29%.

Wall Street Analysts Forecast Growth

AME has been the topic of a number of recent research reports. Mizuho set a $212.00 price objective on shares of AMETEK in a research note on Friday, May 16th. Wall Street Zen upgraded shares of AMETEK from a "hold" rating to a "buy" rating in a report on Monday, May 12th. Robert W. Baird lowered their price target on shares of AMETEK from $197.00 to $190.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 7th. Royal Bank Of Canada lifted their price target on shares of AMETEK from $194.00 to $201.00 and gave the company an "outperform" rating in a research note on Friday, May 2nd. Finally, Truist Financial lifted their price objective on shares of AMETEK from $196.00 to $200.00 and gave the company a "buy" rating in a research report on Monday, May 5th. One analyst has rated the stock with a sell rating, three have issued a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $197.89.

AMETEK Company Profile

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.